SIA
BVS icon

SkyView Investment Advisors’s Bioventus BVS Stock Holding History

SkyView Investment Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-50,000
Closed -$54K – 774
2023
Q1 		$54K Buy
+50,000
New +$95.6K 0.01% 398

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SkyView Investment Advisors's BVS Position: Q2 2023 in Review

SkyView Investment Advisors sold out of Bioventus (BVS) in Q2 2023, closing a stake of 50,000 shares — an estimated $54K sold.

SkyView Investment Advisors first reported a position in BVS in Q1 2023 and held it in 1 quarter. The position peaked at $54K in Q1 2023. 66 funds tracked by Wall St. Rank hold BVS as of Q2 2023.

  • SkyView Investment Advisors reported no remaining Bioventus position as of Q2 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 50,000 Bioventus shares in Q2 2023, an estimated $54K.
  • SkyView Investment Advisors first reported a position in Bioventus in Q1 2023 and held it in 1 quarter.
  • SkyView Investment Advisors's Bioventus position peaked at $54K in Q1 2023.
  • 66 funds tracked by Wall St. Rank held Bioventus as of Q2 2023.

Based on SkyView Investment Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.